1. Home
  2. PERF vs CRBP Comparison

PERF vs CRBP Comparison

Compare PERF & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perfect Corp.

PERF

Perfect Corp.

HOLD

Current Price

$1.71

Market Cap

173.1M

Sector

Technology

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$10.02

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PERF
CRBP
Founded
2015
2009
Country
Taiwan
United States
Employees
353
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.1M
147.4M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PERF
CRBP
Price
$1.71
$10.02
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$45.60
AVG Volume (30 Days)
297.4K
193.4K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$12.93
N/A
Revenue Next Year
$9.44
$100.00
P/E Ratio
$26.42
N/A
Revenue Growth
N/A
97.62
52 Week Low
$1.24
$5.78
52 Week High
$2.67
$20.56

Technical Indicators

Market Signals
Indicator
PERF
CRBP
Relative Strength Index (RSI) 60.05 55.57
Support Level $1.68 $9.86
Resistance Level $1.85 $10.04
Average True Range (ATR) 0.06 0.75
MACD -0.00 0.03
Stochastic Oscillator 90.32 67.69

Price Performance

Historical Comparison
PERF
CRBP

About PERF Perfect Corp.

Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: